# MMEX Resources Corp: financial statements, quarterly

MMEX · OTC · CIK 1440799 · [Communication](/sectors/communication.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/mmex.md) · [Financials](/companies/mmex/financials.md) · [Filings](/companies/mmex/filings.md) · [Insiders](/companies/mmex/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mmex/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [0.0](/filings/0001477932-24-008092.md) | [0.0](/filings/0001477932-25-001722.md) | [0.0 d](/filings/0001477932-25-005291.md) | [0.0](/filings/0001477932-25-006740.md) | [0.0](/filings/0001477932-25-008922.md) | [0.0](/filings/0001477932-26-001284.md) | [0.0 d](/filings/0001477932-26-004593.md) | [0.0](/filings/0001477932-26-005450.md) | [0.0](/filings/0001477932-25-008922.md) | [0.0](/filings/0001477932-26-001284.md) | [0.0 d](/filings/0001477932-26-004593.md) | [0.0](/filings/0001477932-26-005450.md) |
| Selling, general and administrative | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(327)](/filings/0001477932-24-008092.md) | [(329)](/filings/0001477932-25-001722.md) | [(316) d](/filings/0001477932-25-005291.md) | [(365)](/filings/0001477932-25-006740.md) | [(367)](/filings/0001477932-25-008922.md) | [(343)](/filings/0001477932-26-001284.md) | [(362) d](/filings/0001477932-26-004593.md) | [(369)](/filings/0001477932-26-005450.md) | [(307)](/filings/0001477932-25-008922.md) | [(292)](/filings/0001477932-26-001284.md) | [(394) d](/filings/0001477932-26-004593.md) | [(949)](/filings/0001477932-26-005450.md) |
| Interest expense | $k | [109](/filings/0001477932-24-008092.md) | [89.7](/filings/0001477932-25-001722.md) | [42.9 d](/filings/0001477932-25-005291.md) | [90.2](/filings/0001477932-25-006740.md) | [84.2](/filings/0001477932-25-008922.md) | [204](/filings/0001477932-26-001284.md) | [83.3 d](/filings/0001477932-26-004593.md) | [67.6](/filings/0001477932-26-005450.md) | [57.7](/filings/0001477932-25-008922.md) | [58.1](/filings/0001477932-26-001284.md) | [70.6 d](/filings/0001477932-26-004593.md) | [66.8](/filings/0001477932-26-005450.md) |
| Income tax | $k | [0.0](/filings/0001477932-24-008092.md) | [0.0](/filings/0001477932-25-001722.md) | [0.0 d](/filings/0001477932-25-005291.md) | [0.0](/filings/0001477932-25-006740.md) | [0.0](/filings/0001477932-25-008922.md) | [0.0](/filings/0001477932-26-001284.md) | [0.0 d](/filings/0001477932-26-004593.md) | [0.0](/filings/0001477932-26-005450.md) | [0.0](/filings/0001477932-25-008922.md) | [0.0](/filings/0001477932-26-001284.md) | [0.0 d](/filings/0001477932-26-004593.md) | [0.0](/filings/0001477932-26-005450.md) |
| Net income | $k | [(435)](/filings/0001477932-25-001722.md) | [(419)](/filings/0001477932-25-001722.md) | [(426) d](/filings/0001477932-25-005291.md) | [(455)](/filings/0001477932-26-001284.md) | [(471)](/filings/0001477932-26-001284.md) | [(532)](/filings/0001477932-26-001284.md) | [(841) d](/filings/0001477932-26-004593.md) | [(436)](/filings/0001477932-26-005450.md) | [(365)](/filings/0001477932-26-001284.md) | [(350)](/filings/0001477932-26-001284.md) | [(763) d](/filings/0001477932-26-004593.md) | [(792)](/filings/0001477932-26-005450.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001477932-24-008092.md) | [0.00](/filings/0001477932-25-001722.md) | not reported | [0.00](/filings/0001477932-25-006740.md) | [0.00](/filings/0001477932-25-008922.md) | [(0.00)](/filings/0001477932-26-001284.md) | not reported | [0.00](/filings/0001477932-26-005450.md) | [0.00](/filings/0001477932-25-008922.md) | [0.00](/filings/0001477932-26-001284.md) | not reported | [0.00](/filings/0001477932-26-005450.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $k | [5.9](/filings/0001477932-23-009135.md) | [3.0](/filings/0001477932-24-001242.md) | [3.9](/filings/0001477932-25-005291.md) | [3.8](/filings/0001477932-24-005733.md) | [10.4](/filings/0001477932-24-008092.md) | [6.0](/filings/0001477932-25-001722.md) | [8.1](/filings/0001477932-26-004593.md) | [3.1](/filings/0001477932-25-006740.md) | [9.1](/filings/0001477932-25-008922.md) | [14.7](/filings/0001477932-26-001284.md) | [304](/filings/0001477932-26-005450.md) | [2,362](/filings/0001477932-26-005450.md) |
| Total assets | $k | [1,066](/filings/0001477932-23-009135.md) | [1,054](/filings/0001477932-24-001242.md) | [1,045](/filings/0001477932-25-005291.md) | [1,036](/filings/0001477932-24-005733.md) | [1,034](/filings/0001477932-24-008092.md) | [1,020](/filings/0001477932-25-001722.md) | [1,013](/filings/0001477932-26-004593.md) | [999](/filings/0001477932-25-006740.md) | [996](/filings/0001477932-25-008922.md) | [992](/filings/0001477932-26-001284.md) | [1,273](/filings/0001477932-26-005450.md) | [3,333](/filings/0001477932-26-005450.md) |
| Current liabilities | $k | [4,236](/filings/0001477932-23-009135.md) | [4,597](/filings/0001477932-24-001242.md) | [4,859](/filings/0001477932-25-005291.md) | [5,266](/filings/0001477932-24-005733.md) | [5,700](/filings/0001477932-24-008092.md) | [6,162](/filings/0001477932-25-001722.md) | [4,795](/filings/0001477932-26-004593.md) | [5,149](/filings/0001477932-25-006740.md) | [5,459](/filings/0001477932-25-008922.md) | [5,708](/filings/0001477932-26-001284.md) | [6,174](/filings/0001477932-26-005450.md) | [5,752](/filings/0001477932-26-005450.md) |
| Total liabilities | $k | [4,236](/filings/0001477932-23-009135.md) | [4,597](/filings/0001477932-24-001242.md) | [4,859](/filings/0001477932-25-005291.md) | [5,266](/filings/0001477932-24-005733.md) | [5,700](/filings/0001477932-24-008092.md) | [6,162](/filings/0001477932-25-001722.md) | [6,996](/filings/0001477932-26-004593.md) | [7,358](/filings/0001477932-25-006740.md) | [6,991](/filings/0001477932-25-008922.md) | [7,338](/filings/0001477932-26-001284.md) | [7,881](/filings/0001477932-26-005450.md) | [6,995](/filings/0001477932-26-005450.md) |
| Long-term debt | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $k | [(3,171)](/filings/0001477932-25-001722.md) | [(3,544)](/filings/0001477932-25-001722.md) | [(3,814)](/filings/0001477932-26-004593.md) | [(4,230)](/filings/0001477932-26-001284.md) | [(4,666)](/filings/0001477932-26-001284.md) | [(5,142)](/filings/0001477932-26-001284.md) | [(5,983)](/filings/0001477932-26-004593.md) | [(6,359)](/filings/0001477932-26-001284.md) | [(5,995)](/filings/0001477932-26-001284.md) | [(6,345)](/filings/0001477932-26-001284.md) | [(6,608)](/filings/0001477932-26-004593.md) | [(3,662)](/filings/0001477932-26-005450.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(137) d](/filings/0001477932-24-008092.md) | [(161) d](/filings/0001477932-25-001722.md) | [(120) d](/filings/0001477932-25-005291.md) | [(108)](/filings/0001477932-25-006740.md) | [(164) d](/filings/0001477932-25-008922.md) | [(115) d](/filings/0001477932-26-001284.md) | [6.0 d](/filings/0001477932-26-004593.md) | [(8.9)](/filings/0001477932-26-005450.md) | [(43.1) d](/filings/0001477932-25-008922.md) | [(93.0) d](/filings/0001477932-26-001284.md) | [(362) d](/filings/0001477932-26-004593.md) | [(1,548)](/filings/0001477932-26-005450.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001477932-24-008092.md) | [0.0 d](/filings/0001477932-25-001722.md) | [0.0 d](/filings/0001477932-25-005291.md) | [0.0](/filings/0001477932-24-005733.md) | [0.0 d](/filings/0001477932-24-008092.md) | [0.0 d](/filings/0001477932-25-001722.md) | [0.0 d](/filings/0001477932-26-004593.md) | [0.0](/filings/0001477932-26-005450.md) | not reported | not reported | not reported | [11.9](/filings/0001477932-26-005450.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2022-07-31) | Q2 FY2023 (2022-10-31) | Q3 FY2023 (2023-01-31) | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [0.0](/filings/0001477932-22-006890.md) | [0.0](/filings/0001477932-22-009083.md) | [0.0](/filings/0001477932-23-001454.md) | [7.0](/filings/0001477932-24-008092.md) | [8.3](/filings/0001477932-25-001722.md) | [9.5](/filings/0001477932-25-006740.md) | [9.7](/filings/0001477932-25-008922.md) | [10.2](/filings/0001477932-26-001284.md) | [11.5](/filings/0001477932-26-005450.md) | [18.2](/filings/0001477932-25-008922.md) | [22.3](/filings/0001477932-26-001284.md) | [22.3](/filings/0001477932-26-005450.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,295,726,723 at 2026-09-08, from the cover of the [10-Q filed 2026-09-08](/filings/0001477932-26-005450.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.